4.4 Article

Community-based heat-sensitive moxibustion for primary hypertension: study protocol for a randomized controlled trial with patient-preference arms

期刊

TRIALS
卷 23, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13063-022-06092-4

关键词

Heat-sensitive moxibustion; Primary hypertension; Community healthcare; Pragmatic trial

资金

  1. National Natural Science Foundation of China [81904057]
  2. Jiangxi University of Chinese Medicine Innovation and Entrepreneurship Training Plan Program (Jiangxi University of Chinese Medicine) [202010412194]
  3. Science and Technology Project of Department of Education of Jiangxi Province (Department of Education of Jiangxi Province) [GJJ180696]
  4. Jiangxi University of Chinese Medicine 1050 Youth Talent Project (Jiangxi University of Chinese Medicine) [5142001011]

向作者/读者索取更多资源

This study aims to investigate the effectiveness and safety of heat-sensitive moxibustion (HSM) for the treatment of primary hypertension in the community. Through a randomized controlled trial, the study will compare the effects of HSM with conventional treatment methods, including changes in blood pressure, medication dosage, quality of life, severity of symptoms, and incidence of cardiovascular events.
Background: Low- and middle-income countries have a high prevalence of primary hypertension, but its treatment and control are often low. Heat-sensitive moxibustion (HSM), an innovative acupoint stimulation technique, may be effective for treating hypertension and thus used appropriately in primary healthcare. The objective of this study is to investigate whether HSM is effective and safe for the treatment of primary hypertension in the community. Methods: This study is a multicenter, pragmatic, randomized controlled trial (RCT) with patient-preference arms. Four hundred patients with primary hypertension from seven communities will be enrolled. Initially, the communities will be randomly assigned into two study clusters, one using compulsory randomization and the other allowing treatment selection by patient preferences. Then, patients in the compulsory randomization cluster will be randomized to receive HSM plus their original antihypertensive regimen (HSM group) or only their original antihypertensive regimen (control group) for 6 months. Patients in the patient preference cluster may choose to receive HSM or control if they have a preference; otherwise, patients will be randomly assigned. The primary outcome is the change in systolic blood pressure from baseline; secondary outcomes include change in diastolic blood pressure, dosage of antihypertensive drugs, quality of life (QoL), severity of hypertensive symptoms, and incidence of cardiovascular events. Patient compliance with the HSM regimen, the cost-effectiveness ratio, and safety outcomes will also be evaluated. Outcome data will be collected at 6 monthly visits. Discussion: This trial will provide important evidence regarding HSM as a technique for primary hypertension in primary healthcare settings. Given the randomization with patient preferences considered, the trial will also allow analyzing patient-preference effects and the comparison of randomized and nonrandomized samples, to improve the robustness and extrapolation of study conclusions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据